Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T21:37:23.999Z.
Calculation as of: 2026-10-06T21:37:23.999Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4147f1633fe526555426f89ecb5945f37dfc8ef4561f7e6db8f1148c00751c21
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$5.79B
Price/FCF Ratio
N/A
TTM Avg
1.10
3Y Avg
1.10
5Y Avg
1.10
Market Cap
$5.87B
Price/FCF Ratio
32.08
TTM Avg
31.84
3Y Avg
57.87
5Y Avg
58.75
Market Cap
$5.95B
Price/FCF Ratio
45.30
TTM Avg
84.29
3Y Avg
54.39
5Y Avg
39.76
Market Cap
$5.52B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.23B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | $5.78B | N/A | N/A | N/A | N/A |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | N/A | 1.10 | 1.10 | 1.10 |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 32.08 | 31.84 | 57.87 | 58.75 |
| GRAIL Inc. (GRAL)vs › | $5.89B | N/A | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.61B | N/A | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 45.30 | 84.29 | 54.39 | 39.76 |
| RadNet, Inc. (RDNT)vs › | $5.53B | N/A | 80.60 | 77.93 | 72.44 |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | N/A | N/A | N/A | N/A |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | N/A | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | N/A | 10.35 | 10.35 | 10.35 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
